US Patent Issued to VERITAS DIAGNOSTIC on July 29 for "Microfluidic platform and a method for electrostatically-enhanced, excitation-modulated reverse transcriptase quantitative polymerase chain reaction analysis" (British, American Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,738, issued on July 29, was assigned to VERITAS DIAGNOSTIC LLC (New York City, N.Y.).

"Microfluidic platform and a method for electrostatically-enhanced, excitation-modulated reverse transcriptase quantitative polymerase chain reaction analysis" was invented by Martyn Neil Gilbert (Cambridge, Great Britain) and Peter Hornick (New York City, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A reverse transcriptase quantitative polymerase chain reaction based analyzing system includes a sampling tube. The sampling tube includes a tube portion, a cap coupled to the tube portion via a ratchet locking mechanism. The system comprises a microfluidic proc...